Sihuan Pharmaceutical Holdings Group Ltd - Product Pipeline Review

Global Markets Direct’s, ‘Sihuan Pharmaceutical Holdings Group Ltd - Product Pipeline Review - 2016’, provides an overview of the Sihuan Pharmaceutical Holdings Group Ltd’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Sihuan Pharmaceutical Holdings Group Ltd, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Sihuan Pharmaceutical Holdings Group Ltd

The report provides overview of Sihuan Pharmaceutical Holdings Group Ltd including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Sihuan Pharmaceutical Holdings Group Ltd’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Sihuan Pharmaceutical Holdings Group Ltd’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Sihuan Pharmaceutical Holdings Group Ltd’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Sihuan Pharmaceutical Holdings Group Ltd

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Sihuan Pharmaceutical Holdings Group Ltd’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Sihuan Pharmaceutical ...

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Sihuan Pharmaceutical Holdings Group Ltd Snapshot 6

Sihuan Pharmaceutical Holdings Group Ltd Overview 6

Key Facts 6

Sihuan Pharmaceutical Holdings Group Ltd - Research and Development Overview 7

Key Therapeutic Areas 7

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Pipeline Products - Partnered Products 11

Partnered Products/Combination Treatment Modalities 12

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products Glance 13

Sihuan Pharmaceutical Holdings Group Ltd - Late Stage Pipeline Products 13

Pre-Registration Products/Combination Treatment Modalities 13

Sihuan Pharmaceutical Holdings Group Ltd - Clinical Stage Pipeline Products 14

Phase II Products/Combination Treatment Modalities 14

Sihuan Pharmaceutical Holdings Group Ltd - Early Stage Pipeline Products 15

IND/CTA Filed Products/Combination Treatment Modalities 15

Preclinical Products/Combination Treatment Modalities 16

Sihuan Pharmaceutical Holdings Group Ltd - Unknown Stage Pipeline Products 17

Unknown Products/Combination Treatment Modalities 17

Sihuan Pharmaceutical Holdings Group Ltd - Drug Profiles 18

BR-01 - Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

cinepazide mesylate - Drug Profile 19

Product Description 19

Mechanism Of Action 19

R&D Progress 19

cyclosporine - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

JK-05 - Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

levophencynonate hydrochloride - Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

pinoxacin hydrochloride - Drug Profile 28

Product Description 28

Mechanism Of Action 28

R&D Progress 28

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Analysis 29

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Target 29

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Route of Administration 30

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Molecule Type 31

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Mechanism of Action 32

Sihuan Pharmaceutical Holdings Group Ltd - Dormant Projects 33

Sihuan Pharmaceutical Holdings Group Ltd - Discontinued Pipeline Products 34

Discontinued Pipeline Product Profiles 34

cyclosporine 34

Sihuan Pharmaceutical Holdings Group Ltd - Locations And Subsidiaries 35

Head Office 35

Other Locations & Subsidiaries 35

Appendix 36

Methodology 36

Coverage 36

Secondary Research 36

Primary Research 36

Expert Panel Validation 36

Contact Us 36

Disclaimer 37

List of Tables

List of Tables

Sihuan Pharmaceutical Holdings Group Ltd, Key Facts 6

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Indication, 2016 8

Sihuan Pharmaceutical Holdings ...

List of Tables

Sihuan Pharmaceutical Holdings Group Ltd, Key Facts 6

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Indication, 2016 8

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Stage of Development, 2016 9

Sihuan Pharmaceutical Holdings Group Ltd - Monotherapy Products in Pipeline, 2016 10

Sihuan Pharmaceutical Holdings Group Ltd - Partnered Products in Pipeline, 2016 11

Sihuan Pharmaceutical Holdings Group Ltd - Partnered Products/ Combination Treatment Modalities, 2016 12

Sihuan Pharmaceutical Holdings Group Ltd - Pre-Registration, 2016 13

Sihuan Pharmaceutical Holdings Group Ltd - Phase II, 2016 14

Sihuan Pharmaceutical Holdings Group Ltd - IND/CTA Filed, 2016 15

Sihuan Pharmaceutical Holdings Group Ltd - Preclinical, 2016 16

Sihuan Pharmaceutical Holdings Group Ltd - Unknown, 2016 17

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Target, 2016 29

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Route of Administration, 2016 30

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Molecule Type, 2016 31

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Mechanism of Action, 2016 32

Sihuan Pharmaceutical Holdings Group Ltd - Dormant Developmental Projects,2016 33

Sihuan Pharmaceutical Holdings Group Ltd - Discontinued Pipeline Products, 2016 34

Sihuan Pharmaceutical Holdings Group Ltd, Subsidiaries 35

List of Figures

List of Figures

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Indication, 2016 8

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Stage of Development, ...

List of Figures

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Indication, 2016 8

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Stage of Development, 2016 9

Sihuan Pharmaceutical Holdings Group Ltd - Monotherapy Products in Pipeline, 2016 10

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Target, 2016 29

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Route of Administration, 2016 30

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline by Molecule Type, 2016 31

Sihuan Pharmaceutical Holdings Group Ltd - Pipeline Products by Mechanism of Action, 2016 32

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports